UniProt ID | UB2V1_HUMAN | |
---|---|---|
UniProt AC | Q13404 | |
Protein Name | Ubiquitin-conjugating enzyme E2 variant 1 | |
Gene Name | UBE2V1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 147 | |
Subcellular Localization | Nucleus . Excluded from the nucleolus. | |
Protein Description | Has no ubiquitin ligase activity on its own. The UBE2V1-UBE2N heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through Lys-63. This type of poly-ubiquitination activates IKK and does not seem to involve protein degradation by the proteasome. Plays a role in the activation of NF-kappa-B mediated by IL1B, TNF, TRAF6 and TRAF2. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. Plays a role in the error-free DNA repair pathway and contributes to the survival of cells after DNA damage. Promotes TRIM5 capsid-specific restriction activity and the UBE2V1-UBE2N heterodimer acts in concert with TRIM5 to generate 'Lys-63'-linked polyubiquitin chains which activate the MAP3K7/TAK1 complex which in turn results in the induction and expression of NF-kappa-B and MAPK-responsive inflammatory genes.. | |
Protein Sequence | MAATTGSGVKVPRNFRLLEELEEGQKGVGDGTVSWGLEDDEDMTLTRWTGMIIGPPRTIYENRIYSLKIECGPKYPEAPPFVRFVTKINMNGVNSSNGVVDPRAISVLAKWQNSYSIKVVLQELRRLMMSKENMKLPQPPEGQCYSN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAATTGSGV ------CCCCCCCCC | 17.32 | 25944712 | |
4 | Phosphorylation | ----MAATTGSGVKV ----CCCCCCCCCCC | 23.35 | 29255136 | |
5 | Phosphorylation | ---MAATTGSGVKVP ---CCCCCCCCCCCC | 25.32 | 29255136 | |
7 | Phosphorylation | -MAATTGSGVKVPRN -CCCCCCCCCCCCCC | 38.02 | 29255136 | |
8 (in isoform 7) | Phosphorylation | - | 25.30 | 20068231 | |
8 (in isoform 2) | Phosphorylation | - | 25.30 | 20068231 | |
9 (in isoform 7) | Phosphorylation | - | 6.39 | 20068231 | |
9 (in isoform 2) | Phosphorylation | - | 6.39 | 20068231 | |
10 | Ubiquitination | ATTGSGVKVPRNFRL CCCCCCCCCCCCCHH | 50.47 | 23000965 | |
10 | Acetylation | ATTGSGVKVPRNFRL CCCCCCCCCCCCCHH | 50.47 | 25953088 | |
12 | Ubiquitination | TGSGVKVPRNFRLLE CCCCCCCCCCCHHHH | 21.56 | 23000965 | |
18 | Ubiquitination | VPRNFRLLEELEEGQ CCCCCHHHHHHHCCC | 4.13 | 23000965 | |
24 | Ubiquitination | LLEELEEGQKGVGDG HHHHHHCCCCCCCCC | 25.73 | 23000965 | |
26 | Ubiquitination | EELEEGQKGVGDGTV HHHHCCCCCCCCCCE | 67.43 | 23000965 | |
30 (in isoform 6) | Ubiquitination | - | 47.38 | 21890473 | |
30 | Ubiquitination | EGQKGVGDGTVSWGL CCCCCCCCCCEECCC | 47.38 | 23000965 | |
32 | Ubiquitination | QKGVGDGTVSWGLED CCCCCCCCEECCCCC | 18.99 | 23000965 | |
42 | Ubiquitination | WGLEDDEDMTLTRWT CCCCCCCCCEEEEEE | 42.22 | 27667366 | |
54 | Ubiquitination | RWTGMIIGPPRTIYE EEEEEEECCCCEEEC | 18.42 | 32015554 | |
63 | Methylation | PRTIYENRIYSLKIE CCEEECCCEEEEEEE | 19.79 | 115919381 | |
65 | Ubiquitination | TIYENRIYSLKIECG EEECCCEEEEEEECC | 12.52 | 23000965 | |
66 | Phosphorylation | IYENRIYSLKIECGP EECCCEEEEEEECCC | 22.33 | 24719451 | |
66 | Ubiquitination | IYENRIYSLKIECGP EECCCEEEEEEECCC | 22.33 | 32015554 | |
68 | Ubiquitination | ENRIYSLKIECGPKY CCCEEEEEEECCCCC | 30.44 | 23000965 | |
68 | Acetylation | ENRIYSLKIECGPKY CCCEEEEEEECCCCC | 30.44 | 25953088 | |
71 | Ubiquitination | IYSLKIECGPKYPEA EEEEEEECCCCCCCC | 14.93 | 23000965 | |
74 | Acetylation | LKIECGPKYPEAPPF EEEECCCCCCCCCCE | 59.74 | 23749302 | |
74 (in isoform 4) | Ubiquitination | - | 59.74 | 21890473 | |
74 | Ubiquitination | LKIECGPKYPEAPPF EEEECCCCCCCCCCE | 59.74 | 23000965 | |
75 | Ubiquitination | KIECGPKYPEAPPFV EEECCCCCCCCCCEE | 14.94 | 23000965 | |
79 | Ubiquitination | GPKYPEAPPFVRFVT CCCCCCCCCEEEEEE | 22.62 | 23000965 | |
86 | Phosphorylation | PPFVRFVTKINMNGV CCEEEEEEEECCCCC | 24.40 | 18491316 | |
87 | Ubiquitination | PFVRFVTKINMNGVN CEEEEEEEECCCCCC | 27.12 | 23000965 | |
89 | Ubiquitination | VRFVTKINMNGVNSS EEEEEEECCCCCCCC | 21.30 | 23000965 | |
90 | Phosphorylation | RFVTKINMNGVNSSN EEEEEECCCCCCCCC | 5.42 | 33259812 | |
91 | Ubiquitination | FVTKINMNGVNSSNG EEEEECCCCCCCCCC | 46.93 | 23000965 | |
93 | Ubiquitination | TKINMNGVNSSNGVV EEECCCCCCCCCCCC | 5.51 | 23000965 | |
97 (in isoform 7) | Ubiquitination | - | 47.28 | 21890473 | |
97 | Ubiquitination | MNGVNSSNGVVDPRA CCCCCCCCCCCCHHH | 47.28 | 23000965 | |
97 (in isoform 2) | Ubiquitination | - | 47.28 | 21890473 | |
102 | Phosphorylation | SSNGVVDPRAISVLA CCCCCCCHHHHHHHH | 18.92 | 33259812 | |
104 | Phosphorylation | NGVVDPRAISVLAKW CCCCCHHHHHHHHHH | 12.09 | 33259812 | |
106 | Phosphorylation | VVDPRAISVLAKWQN CCCHHHHHHHHHHCC | 15.30 | 26437602 | |
107 | Ubiquitination | VDPRAISVLAKWQNS CCHHHHHHHHHHCCC | 5.01 | 32015554 | |
110 | Ubiquitination | RAISVLAKWQNSYSI HHHHHHHHHCCCCCH | 45.19 | 32015554 | |
114 | Phosphorylation | VLAKWQNSYSIKVVL HHHHHCCCCCHHHHH | 12.73 | 29116813 | |
116 | Phosphorylation | AKWQNSYSIKVVLQE HHHCCCCCHHHHHHH | 18.76 | 24719451 | |
125 | Methylation | KVVLQELRRLMMSKE HHHHHHHHHHHHCHH | 29.00 | - | |
128 | Ubiquitination | LQELRRLMMSKENMK HHHHHHHHHCHHHCC | 2.43 | 23000965 | |
131 | Malonylation | LRRLMMSKENMKLPQ HHHHHHCHHHCCCCC | 34.90 | 26320211 | |
131 | Acetylation | LRRLMMSKENMKLPQ HHHHHHCHHHCCCCC | 34.90 | 23236377 | |
131 | Ubiquitination | LRRLMMSKENMKLPQ HHHHHHCHHHCCCCC | 34.90 | 23000965 | |
131 | 2-Hydroxyisobutyrylation | LRRLMMSKENMKLPQ HHHHHHCHHHCCCCC | 34.90 | - | |
132 | Ubiquitination | RRLMMSKENMKLPQP HHHHHCHHHCCCCCC | 56.07 | 23000965 | |
133 | Ubiquitination | RLMMSKENMKLPQPP HHHHCHHHCCCCCCC | 36.30 | 32015554 | |
135 | Ubiquitination | MMSKENMKLPQPPEG HHCHHHCCCCCCCCC | 69.47 | 23000965 | |
143 | Phosphorylation | LPQPPEGQCYSN--- CCCCCCCCCCCC--- | 22.70 | 33259812 | |
145 | Phosphorylation | QPPEGQCYSN----- CCCCCCCCCC----- | 11.89 | 23911959 | |
146 | Phosphorylation | PPEGQCYSN------ CCCCCCCCC------ | 43.63 | 25159151 | |
148 (in isoform 1) | Ubiquitination | - | 21890473 | ||
154 | Ubiquitination | N-------------- C-------------- | 23000965 | ||
158 | Ubiquitination | ------------------ ------------------ | 23000965 | ||
169 | Phosphorylation | ----------------------------- ----------------------------- | 33259812 | ||
291 | Ubiquitination | ------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------- | 23000965 | ||
297 | Ubiquitination | ------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- | 23000965 | ||
333 | Ubiquitination | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 32015554 | ||
354 | Ubiquitination | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 23000965 | ||
358 | Ubiquitination | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 23000965 | ||
369 | Phosphorylation | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 33259812 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UB2V1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UB2V1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146, AND MASSSPECTROMETRY. |